Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05739149

A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers

Conditions: Non-Healing Ulcer of Skin, Non-healing Wound, Lower Extremity Wound

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 10
Sponsor: Mayo Clinic

Location: United States

Summary

The purpose of this research is to explore the use of high-resolution microvessel ultrasound imaging system to look for scarring and to monitor wound healing and to see if treatment affects the amount of tiny vessels and circulation around the wound.

Eligibility Criteria

Inclusion Criteria:Chronic wound in the course of diabetic foot ulcers and/or lower extremity venous ulcers with duration of at least 6 weeks and the wound surface not less than 2 sq. cm and not greater than 15 sq. cm, without evidence of active infection of the wound at the time of qualification to participate in the studyMeets criteria for stalled chronic wound defined as less than 50% reduction in wound size after 30 days of standard of care management.For chronic venous ulcers, ultrasound demonstrates venous reflux >0.5 secondsSatisfactory blood glucose control - fasting not more than 110 mg%, HbA1c <6.5%Satisfactory blood supply to the wound verified by the measurement of the oxygen level of the foot tissue (TCPO2 > 30mmHg) in patients with neuropathic etiology of diabetic foot syndromeIn the case of the patients with the wounds of ischemic component, the condition for qualification is a clinical improvement of the limb's blood supply as a result of the revascularization procedure documented by ultrasound.Ankle-brachial index (ABI) ≥ 0.8Exclusion Criteria:Acute wound with duration less than 6 weeksEvidence of active infection or on antibioticsSmokerFor chronic venous ulcers, ultrasound demonstrates venous reflux <0.5 secondsUnsatisfactory blood glucose control - fasting more than 110 mg%, HbA1c <6.5%Poor blood supply to the wound verified by the measurement of the oxygen level of the foot tissue (TCPO2 < 30mmHg) in patients with neuropathic etiology of diabetic foot syndromeAnkle-brachial index (ABI) < 0.PregnancyKnown allergy to lidocaine

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05739149). StuddyBuddy aggregates publicly available trial information.